Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:46 AM UTC
| NCT Number | NCT06162221 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 616 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | February 10, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06162221 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 22 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06162221 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06162221 was last updated 2 weeks ago (February 10, 2026). HelloStudys verifies this status automatically.